RESEARCH TRIANGLE PARK, N.C. – June 23, 2014 – Quintiles, the world’s largest biopharmaceutical services provider and a Fortune 500 company, has been named one of IDG Computerworld's 100 Best Places to Work in IT 2014, the sixth time it has received this employer distinction over the past seven years.
Computerworld has ranked the top 100 work environments for technology professionals at U.S. companies or U.S. staff of international companies each year since 1994. The list is compiled each year based on company offerings in categories such as benefits, career development, training and retention. In addition, Computerworld conducts extensive surveys of IT workers with their responses factoring heavily in determining the rankings.
“We are delighted to be named for the sixth time as one of the top IT workplaces,” said Quintiles Chief Information Officer Richard Thomas. “It is testament to the quality of our team and their focus on creating value over the long haul. The human edge in technology is more critical now than ever. Having a great workplace and culture is our foundation, and it allows everyone to flourish professionally, lifting our team performance to ever higher levels in everything we do," Thomas added.
"Hiring the best and the brightest IT pros, offering them competitive pay and providing top-notch benefits is just the beginning for the outstanding employers on this year's Best Places to Work in IT list," said Scot Finnie, editor in chief of Computerworld. "Both newcomers to the list and rock-steady stalwarts nurture their talent with challenging business-critical projects, extensive training opportunities and ongoing career development programs. They invest in their own futures by investing in their employees."
Quintiles has been recognized on numerous occasions for its pioneering work in IT, recently being named to the "CIO 100" by CIO magazine for creating business value through the effective and innovative use of IT. In 2013, Quintiles received the SCRIP industry award for best technological development in clinical trials, and also took home the Computerworld Data+ Editor’s Choice Award for its Infosario® platform big data solutions that help pharmaceutical organizations improve their probability of success throughout the drug development process.
Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 29,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com
Contact:Phil Bridges, Media Relations (email@example.com)
+ 1.919.998.1653 (office) +1.919.457.6347 (mobile)
Karl Deonanan, Investor Relations (InvestorRelations@quintiles.com)